As a web platform for scientific research, Kontiki Research Services (KRS) includes:

• Open technologies for advancing research and gaining publications,
• Funding to further develop open technologies,
• An asset exchange that hosts freely available equipment and supplies,
• A manuscript development process,
• A preprint server for hosting manuscripts and many more.

Goals of our therapeutic area include lowering technology and pharmaceutical costs, reducing the risks and time to develop life-saving therapies, and broadening markets for therapeutics, particularly for underserved populations around the world.

The Kontiki Research platform enables scientists to develop and publish research easily. Organizations with dormant and abandoned life science intellectual properties (IP) are encouraged to freely provide that IP to the community.

KRS simple tools enable more effective collaboration. Freely available technologies, assets, and funding, should lead to better therapeutics for patients everywhere.

The Kontiki Research platform is freely available to all scientists and researchers!

KRS integrates a novel pre-peer review process, preprint server for open access publishing, open data, artificial intelligence, and managing grant funds via blockchain, all into a unified crowdsourcing research ecosystem.

Researchers at non-profit and for-profit organizations are welcome to join, for free, and gain access to all of Kontiki Research unique features. There are no hurdles to join KRS, including no subscription or pay-wall.

In exchange for gaining access to funding, free technologies, and a collaborative manuscript development platform, adopting researchers need only agree to freely provide their progress back to the scientific community where we belong.